Sex- and Gender-Based Reporting in Antihypertensive Medication Literature Informing Hypertension Guidelines.

ABSTRACT:

Background

Hypertension is the leading modifiable cardiovascular risk factor with recognized sex- and gender-based differences. We assessed the incorporation of sex and gender reporting in the antihypertensive medication literature informing hypertension guidelines.

Methods and results

Literature cited in the International Society of Hypertension (2020), European Society of Cardiology/European Society of Hypertension (2018), American College of Cardiology/American Heart Association (2017), Latin American Society of Hypertension (2017), Pan-African Society of Cardiology (2020), and Hypertension Canada (2020) guidelines was systematically reviewed. Observational studies, randomized controlled trials, and systematic reviews involving antihypertensive medications were included.

SUBMITTER: Gulamhusein N 

PROVIDER: S-EPMC10944031 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature